Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii

International Journal of Antimicrobial Agents

Volumn 39, Issue 2, 2012, Pages 180-181

  Kempf, Marie ^a   Djouhri Bouktab, Lamia ^a   Brunel, Jean Michel ^a   Raoult, Didier ^a   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; IMIPENEM; LIPID A; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CASE REPORT; CULTURE MEDIUM; DRUG POTENTIATION; HUMAN; INCUBATION TIME; LETTER; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; COLISTIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; SULBACTAM;

EID: 84855472920     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.10.001     Document Type: Letter

References (5)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538-82.
2. Rolain JM, Roch A, Castanier M, Papazian L, Raoult D. Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France. J Infect Dis 2011;204:1146-7.
3. López-Rojas R, Jiménez-Mejías ME, Lepe JA, Pachón J. Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain. J Infect Dis 2011;204:1147-8.
4. López-Rojas R, Domínguez-Herrera J, McConnell MJ, Docobo-Peréz F, Smani Y, Fernández-Reyes M, et al. Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii. J Infect Dis 2011;203:545-8.
5. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. In vitro activities of the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with β-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 2004;48:1586-92. (Pubitemid 38544363)